Accendra Health received a notice from NYSE that its stock has fallen below $1 per share for 30 consecutive days. The company plans to cure the issue in the next six months, potentially including a reverse stock split.
Accendra Health received a notice from NYSE that its stock has fallen below $1 per share for 30 consecutive days. The company plans to cure the issue in the next six months, potentially including a reverse stock split.